M. Taquet

Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia.

E. Baudin, V. Rohmer, F. Caroli-Bosc, 2013, European journal of endocrinology.

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

G. Canonica, T. Zander, N. Adhikari, 2021, The Lancet Respiratory Medicine.

Loss of adipocyte phospholipase gene PLAAT3 causes lipodystrophy and insulin resistance due to inactivated arachidonic acid-mediated PPARγ signaling

C. Depienne, B. Poppe, D. Hemelsoet, 2021, bioRxiv.

[Cardiac manifestations of pheochromocytoma].

M. Taquet, B. Goichot, J. Schlienger, 2009, Annales d'Endocrinologie.

Head-to-head comparison between SRS, 18F-FDG and 18F-FDOPA PET/CT in a patient with recurrent SDHC-related jugular paraganglioma

F. Hubelé, M. Taquet, B. Goichot, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

Should pituitary carcinoma be treated using a NET‐like approach? A case of complete remission of a metastatic malignant prolactinoma with multimodal therapy including immunotherapy

M. Taquet, B. Goichot, G. Malouf, 2021, Clinical endocrinology.

Identification of chloramphenicol in human hair leading to a diagnosis of factitious disorder

M. Taquet, B. Goichot, J. Raul, 2020, Clinical toxicology.

Loss of phospholipase PLAAT3 causes a mixed lipodystrophic and neurological syndrome due to impaired PPARγ signaling

P. Verloo, D. Hemelsoet, M. Taquet, 2023, Nature Genetics.